NCT05588739

Brief Summary

Youth suicide risk has increased 56% in the last decade, and suicide is the leading cause of preventable death in children and adolescents. Experiencing chronic nightmares doubles the risk of suicidal ideation in children and adolescents. Decades of research support that even when controlling for depression and insomnia, nightmares predict suicidality. Contemporary theories model nightmares as the mediating link between depression and suicide. Numerous studies examine the effect of nightmare-specific therapies on reducing suicide in adults, but none have examined whether nightmare therapies can reduce youth suicidality. The proposed pilot will evaluate the feasibility of the Cognitive Behavioral Therapy for Nightmares in Children paradigm (CBT-NC), recruiting and retaining children ages 6-17 who experience chronic nightmares. Utilizing a waitlist control (WL) model, participants (n=30) will be randomized after baseline assessment to either immediate treatment or a WL. Feasibility will be evaluated by examining retention through treatment (or WL) to post WL and post treatment assessments. Both groups will be evaluated before and after the treatment for suicidal ideation, sleep quality, and nightmare distress and frequency, in order to document improvements due to therapy. The proposed pilot will provide preliminary data about recruitment, retention, and allow for effect size calculations between groups. These results will be used to develop a larger treatment study that would ultimately evaluate the mediating effect of treatment for chronic nightmares on suicidality in children.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2020

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 30, 2020

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

October 3, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

October 20, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 16, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 16, 2023

Completed
Last Updated

June 22, 2023

Status Verified

June 1, 2023

Enrollment Period

2.7 years

First QC Date

October 3, 2022

Last Update Submit

June 16, 2023

Conditions

Keywords

NightmaresChildrenTraumaCBTExposureRelaxationRescriptingCognitiveBehavioralTherapySuicidality

Outcome Measures

Primary Outcomes (8)

  • Change on the Child Adolescent Trauma Screen (CATS) - Child Version

    The CATS screens for child trauma history and PTSD symptoms in youth ages 7-17; 15 YES/NO questions; 1 open-ended question

    Participants will be assessed at Baseline (Week 0) through study completion, up to 15 weeks.

  • Change on the Trauma Related Nightmare Survey - Child Version (TRNS-C)

    The TRNS-C is a 14 item self report questionnaire that assesses current sleep quality, frequency, severity, and duration of nightmares, as well as cognitions, emotions, and behaviors related to nightmares in children.

    Participants will be assessed at Baseline (Week 0) through study completion, up to 15 weeks.

  • Change on Sleep Locus of Control (SLOC)

    The SLOC is an 6 item self report measure perceived contingencies between sleep behavior and events. This scale is collected as a child self report, and a caregiver report regarding child.

    Participants will be assessed at Baseline (Week 0) through study completion, up to 15 weeks.

  • Change on Nightmare Locus of Control (NLOC)

    The N-LOC is an 6 item self report. This scale is collected as a child self report, and a caregiver report regarding child.

    Participants will be assessed at Baseline (Week 0) through study completion, up to 15 weeks.

  • Change in reports on Sleep Journal

    6 question self report that patient assesses daily from home.

    Participants complete this assessment at Pre-treatment (for 1 week), daily during the treatment phase (an average of 5 weeks), at Post treatment (for 1 week).

  • Change on the Child Adolescent Trauma Screen (CATS) - Caregiver Report regarding child

    The CATS screens for child trauma history and PTSD symptoms (information obtained from the caregiver, about the child).

    Participants will be assessed at Baseline (Week 0) through study completion, up to 15 weeks.

  • Change on Center for Epidemiologic Studies Beliefs and Attitudes About Sleep Scale (DBAS-16)

    The DBAS-16 is a 16-item self-report measure that evaluates the role of sleep related beliefs. The score is a sum of the 16 items, ranging from 16 to 80. Higher scores represent more dysfunctional beliefs about sleep.

    Participants will be assessed at Baseline (Week 0) through study completion, up to 15 weeks.

  • Change on Center for Epidemiologic Studies Depression Scale for Children (CES-DC)

    The CES-DC is a 20-item self-report depression inventory. A score of 15 or higher indicates significant levels of depression.

    Participants will be assessed at Baseline (Week 0) and after post-condition (Week 6).

Study Arms (2)

Treatment Right-Away

EXPERIMENTAL

Cognitive Behavioral Therapy using exposure, relaxation, and rescripting - Child utilizes behavioral and cognitive therapy techniques of exposure therapy and cognitive restructuring.

Behavioral: Cognitive Behavioral Therapy

Waitlist Control

NO INTERVENTION

Waitlist control group will complete pre and post assessments at beginning and end of wait period.

Interventions

The manualized CBT protocol is five session that teach sleep hygiene, relaxation strategies, and addresses nightmares therapeutically through exposure and rescripting.

Treatment Right-Away

Eligibility Criteria

Age6 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Child must be between the ages of 6-17 years 11 months.
  • Child must report recurrent nightmares that meet DSM criteria for nightmare disorder.
  • Child must speak and understand English at no less than a 6 year old level.
  • Children on prescribed psychotropic medications must be stable for 30 days prior to enrolling.
  • Child must have a parent or legal guardian attend study visits with them.
  • Participants must have access to WIFI/phone data in order to participate in this study, and must have an electronic device with a camera enabled. Our study team will have the capability of driving a tablet to the participant's home if that is the only reason they cannot participate, and if the family lives within the greater Tulsa area.

You may not qualify if:

  • Children with a previous diagnosis of sleep apnea which is not adequately treated.
  • Children whose receptive/expressive language skills are below a 6 year old level.
  • If it is determined that a child is actively suicidal and at imminent risk for self-harm, the family will be notified and referred for immediate care. They will not be eligible for the study until they are deemed stable.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Tulsa

Tulsa, Oklahoma, 74104, United States

Location

University of Oklahoma School of Community Medicine

Tulsa, Oklahoma, 74135, United States

Location

Related Publications (1)

  • Cromer LD, Bell SB, Prince LE, Hollman N, El Sabbagh E, Buck TR. Efficacy of a telehealth cognitive behavioral therapy for improving sleep and nightmares in children aged 6-17. Front Sleep. 2024 Jul 11;3:1401023. doi: 10.3389/frsle.2024.1401023. eCollection 2024.

MeSH Terms

Conditions

Wounds and InjuriesBehaviorSuicidal Ideation

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

SuicideSelf-Injurious BehaviorBehavioral Symptoms

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Blinded randomization into 2 groups: Treatment \& Waitlist Control. Treatment group receives treatment right away. Waitlist group receives treatment after a 5 week wait.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 3, 2022

First Posted

October 20, 2022

Study Start

September 30, 2020

Primary Completion

June 16, 2023

Study Completion

June 16, 2023

Last Updated

June 22, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations